Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Maternal Pertussis Vaccine for Newborn Protection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.In 2024, global Maternal Pertussis Vaccine for Newborn Protection production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. Maternal Pertussis Vaccine for Newborn Protection is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71?85% effective. In this report, we cover all the pertussis-containing vaccines. Gross margin for the Maternal Pertussis Vaccine for Newborn Protection in general shows that manufacturers often achieve roughly 50?70% gross margins, depending on the producer, country, and contract.The global Maternal Pertussis Vaccine for Newborn Protection market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The Maternal Pertussis Vaccine for Newborn Protection industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for Maternal Pertussis Vaccine for Newborn Protections is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.
The global Maternal Pertussis Vaccine for Newborn Protection market size was estimated at USD 5766.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Maternal Pertussis Vaccine for Newborn Protection market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Maternal Pertussis Vaccine for Newborn Protection market.
Global Maternal Pertussis Vaccine for Newborn Protection Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Market Segmentation (by Type)
DTaP
Tdap
DTwP
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Maternal Pertussis Vaccine for Newborn Protection Market
Overview of the regional outlook of the Maternal Pertussis Vaccine for Newborn Protection Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Maternal Pertussis Vaccine for Newborn Protection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Maternal Pertussis Vaccine for Newborn Protection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Maternal Pertussis Vaccine for Newborn Protection market size was estimated at USD 5766.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Maternal Pertussis Vaccine for Newborn Protection market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Maternal Pertussis Vaccine for Newborn Protection market.
Global Maternal Pertussis Vaccine for Newborn Protection Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Market Segmentation (by Type)
DTaP
Tdap
DTwP
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Maternal Pertussis Vaccine for Newborn Protection Market
Overview of the regional outlook of the Maternal Pertussis Vaccine for Newborn Protection Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Maternal Pertussis Vaccine for Newborn Protection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Maternal Pertussis Vaccine for Newborn Protection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Maternal Pertussis Vaccine for Newborn Protection
1.2 Key Market Segments
1.2.1 Maternal Pertussis Vaccine for Newborn Protection Segment by Type
1.2.2 Maternal Pertussis Vaccine for Newborn Protection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Maternal Pertussis Vaccine for Newborn Protection Product Life Cycle
3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Manufacturers (2020-2025)
3.4 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2020-2025)
3.5 Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation and Trends
3.8.1 Maternal Pertussis Vaccine for Newborn Protection Market Concentration Rate
3.8.2 Global 5 and 10 Largest Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION INDUSTRY CHAIN ANALYSIS
4.1 Maternal Pertussis Vaccine for Newborn Protection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Maternal Pertussis Vaccine for Newborn Protection Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Maternal Pertussis Vaccine for Newborn Protection Market
5.7 ESG Ratings of Leading Companies
6 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2025)
6.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type (2020-2025)
6.4 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2025)
7 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Sales by Application (2020-2025)
7.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) by Application (2020-2025)
7.4 Global Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate by Application (2020-2025)
8 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET SALES BY REGION
8.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region
8.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region
8.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region
8.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.3 North America
8.3.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country
8.3.2 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country
8.4.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region
8.5.2 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country
8.6.2 South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Region
8.7.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET PRODUCTION BY REGION
9.1 Global Production of Maternal Pertussis Vaccine for Newborn Protection by Region(2020-2025)
9.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2025)
9.3 Global Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Maternal Pertussis Vaccine for Newborn Protection Production
9.4.1 North America Maternal Pertussis Vaccine for Newborn Protection Production Growth Rate (2020-2025)
9.4.2 North America Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Maternal Pertussis Vaccine for Newborn Protection Production
9.5.1 Europe Maternal Pertussis Vaccine for Newborn Protection Production Growth Rate (2020-2025)
9.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Maternal Pertussis Vaccine for Newborn Protection Production (2020-2025)
9.6.1 Japan Maternal Pertussis Vaccine for Newborn Protection Production Growth Rate (2020-2025)
9.6.2 Japan Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Maternal Pertussis Vaccine for Newborn Protection Production (2020-2025)
9.7.1 China Maternal Pertussis Vaccine for Newborn Protection Production Growth Rate (2020-2025)
9.7.2 China Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Basic Information
10.1.2 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.1.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.1.4 Sanofi Pasteur Business Overview
10.1.5 Sanofi Pasteur SWOT Analysis
10.1.6 Sanofi Pasteur Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.2.3 GSK Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Mitsubishi Tanabe Pharma
10.3.1 Mitsubishi Tanabe Pharma Basic Information
10.3.2 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.3.3 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.3.4 Mitsubishi Tanabe Pharma Business Overview
10.3.5 Mitsubishi Tanabe Pharma SWOT Analysis
10.3.6 Mitsubishi Tanabe Pharma Recent Developments
10.4 KM Biologics
10.4.1 KM Biologics Basic Information
10.4.2 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.4.3 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.4.4 KM Biologics Business Overview
10.4.5 KM Biologics Recent Developments
10.5 Wuhan Institute of Biological Products
10.5.1 Wuhan Institute of Biological Products Basic Information
10.5.2 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.5.3 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.5.4 Wuhan Institute of Biological Products Business Overview
10.5.5 Wuhan Institute of Biological Products Recent Developments
10.6 Walvax Biotechnology
10.6.1 Walvax Biotechnology Basic Information
10.6.2 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.6.3 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.6.4 Walvax Biotechnology Business Overview
10.6.5 Walvax Biotechnology Recent Developments
10.7 Chengdu Institute of Biological Products
10.7.1 Chengdu Institute of Biological Products Basic Information
10.7.2 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.7.3 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.7.4 Chengdu Institute of Biological Products Business Overview
10.7.5 Chengdu Institute of Biological Products Recent Developments
10.8 Minhai Biotechnology
10.8.1 Minhai Biotechnology Basic Information
10.8.2 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.8.3 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.8.4 Minhai Biotechnology Business Overview
10.8.5 Minhai Biotechnology Recent Developments
11 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET FORECAST BY REGION
11.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast
11.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country
11.2.3 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Region
11.2.4 South America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Maternal Pertussis Vaccine for Newborn Protection by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Maternal Pertussis Vaccine for Newborn Protection by Type (2026-2035)
12.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Maternal Pertussis Vaccine for Newborn Protection by Type (2026-2035)
12.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Forecast by Application (2026-2035)
12.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) Forecast by Application
12.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Maternal Pertussis Vaccine for Newborn Protection
1.2 Key Market Segments
1.2.1 Maternal Pertussis Vaccine for Newborn Protection Segment by Type
1.2.2 Maternal Pertussis Vaccine for Newborn Protection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Maternal Pertussis Vaccine for Newborn Protection Product Life Cycle
3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Manufacturers (2020-2025)
3.4 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2020-2025)
3.5 Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation and Trends
3.8.1 Maternal Pertussis Vaccine for Newborn Protection Market Concentration Rate
3.8.2 Global 5 and 10 Largest Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION INDUSTRY CHAIN ANALYSIS
4.1 Maternal Pertussis Vaccine for Newborn Protection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Maternal Pertussis Vaccine for Newborn Protection Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Maternal Pertussis Vaccine for Newborn Protection Market
5.7 ESG Ratings of Leading Companies
6 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2025)
6.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type (2020-2025)
6.4 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2025)
7 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Sales by Application (2020-2025)
7.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) by Application (2020-2025)
7.4 Global Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate by Application (2020-2025)
8 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET SALES BY REGION
8.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region
8.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region
8.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region
8.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.3 North America
8.3.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country
8.3.2 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country
8.4.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region
8.5.2 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country
8.6.2 South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Region
8.7.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET PRODUCTION BY REGION
9.1 Global Production of Maternal Pertussis Vaccine for Newborn Protection by Region(2020-2025)
9.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2025)
9.3 Global Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Maternal Pertussis Vaccine for Newborn Protection Production
9.4.1 North America Maternal Pertussis Vaccine for Newborn Protection Production Growth Rate (2020-2025)
9.4.2 North America Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Maternal Pertussis Vaccine for Newborn Protection Production
9.5.1 Europe Maternal Pertussis Vaccine for Newborn Protection Production Growth Rate (2020-2025)
9.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Maternal Pertussis Vaccine for Newborn Protection Production (2020-2025)
9.6.1 Japan Maternal Pertussis Vaccine for Newborn Protection Production Growth Rate (2020-2025)
9.6.2 Japan Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Maternal Pertussis Vaccine for Newborn Protection Production (2020-2025)
9.7.1 China Maternal Pertussis Vaccine for Newborn Protection Production Growth Rate (2020-2025)
9.7.2 China Maternal Pertussis Vaccine for Newborn Protection Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Basic Information
10.1.2 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.1.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.1.4 Sanofi Pasteur Business Overview
10.1.5 Sanofi Pasteur SWOT Analysis
10.1.6 Sanofi Pasteur Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.2.3 GSK Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Mitsubishi Tanabe Pharma
10.3.1 Mitsubishi Tanabe Pharma Basic Information
10.3.2 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.3.3 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.3.4 Mitsubishi Tanabe Pharma Business Overview
10.3.5 Mitsubishi Tanabe Pharma SWOT Analysis
10.3.6 Mitsubishi Tanabe Pharma Recent Developments
10.4 KM Biologics
10.4.1 KM Biologics Basic Information
10.4.2 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.4.3 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.4.4 KM Biologics Business Overview
10.4.5 KM Biologics Recent Developments
10.5 Wuhan Institute of Biological Products
10.5.1 Wuhan Institute of Biological Products Basic Information
10.5.2 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.5.3 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.5.4 Wuhan Institute of Biological Products Business Overview
10.5.5 Wuhan Institute of Biological Products Recent Developments
10.6 Walvax Biotechnology
10.6.1 Walvax Biotechnology Basic Information
10.6.2 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.6.3 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.6.4 Walvax Biotechnology Business Overview
10.6.5 Walvax Biotechnology Recent Developments
10.7 Chengdu Institute of Biological Products
10.7.1 Chengdu Institute of Biological Products Basic Information
10.7.2 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.7.3 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.7.4 Chengdu Institute of Biological Products Business Overview
10.7.5 Chengdu Institute of Biological Products Recent Developments
10.8 Minhai Biotechnology
10.8.1 Minhai Biotechnology Basic Information
10.8.2 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Overview
10.8.3 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Market Performance
10.8.4 Minhai Biotechnology Business Overview
10.8.5 Minhai Biotechnology Recent Developments
11 MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION MARKET FORECAST BY REGION
11.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast
11.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country
11.2.3 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Region
11.2.4 South America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Maternal Pertussis Vaccine for Newborn Protection by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Maternal Pertussis Vaccine for Newborn Protection by Type (2026-2035)
12.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Maternal Pertussis Vaccine for Newborn Protection by Type (2026-2035)
12.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Forecast by Application (2026-2035)
12.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) Forecast by Application
12.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type (M USD)
Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
Table 5. Maternal Pertussis Vaccine for Newborn Protection Market Size Comparison by Region (M USD)
Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Maternal Pertussis Vaccine for Newborn Protection as of 2025)
Table 11. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Maternal Pertussis Vaccine for Newborn Protection Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (K MT)
Table 27. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type (M USD)
Table 28. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) by Type (2020-2025)
Table 29. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2025)
Table 30. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) by Type (2020-2025)
Table 31. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type (2020-2025)
Table 32. Global Maternal Pertussis Vaccine for Newborn Protection Price (USD/KG) by Type (2020-2025)
Table 33. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) by Application
Table 34. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
Table 35. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2025) & (K MT)
Table 36. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2025)
Table 37. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application (2020-2025) & (M USD)
Table 38. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application (2020-2025)
Table 39. Global Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate by Application (2020-2025)
Table 40. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (K MT)
Table 41. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2025)
Table 42. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025) & (M USD)
Table 43. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025)
Table 44. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K MT)
Table 45. North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K MT)
Table 47. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025) & (M USD)
Table 50. South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K MT)
Table 51. South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025) & (M USD)
Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Production (K MT) by Region(2020-2025)
Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2025)
Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Pasteur Basic Information
Table 63. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 64. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Pasteur Business Overview
Table 66. Sanofi Pasteur SWOT Analysis
Table 67. Sanofi Pasteur Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 70. GSK Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Mitsubishi Tanabe Pharma Basic Information
Table 75. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 76. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Mitsubishi Tanabe Pharma Business Overview
Table 78. Mitsubishi Tanabe Pharma SWOT Analysis
Table 79. Mitsubishi Tanabe Pharma Recent Developments
Table 80. KM Biologics Basic Information
Table 81. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 82. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. KM Biologics Business Overview
Table 84. KM Biologics Recent Developments
Table 85. Wuhan Institute of Biological Products Basic Information
Table 86. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 87. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Wuhan Institute of Biological Products Business Overview
Table 89. Wuhan Institute of Biological Products Recent Developments
Table 90. Walvax Biotechnology Basic Information
Table 91. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 92. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Walvax Biotechnology Business Overview
Table 94. Walvax Biotechnology Recent Developments
Table 95. Chengdu Institute of Biological Products Basic Information
Table 96. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 97. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Chengdu Institute of Biological Products Business Overview
Table 99. Chengdu Institute of Biological Products Recent Developments
Table 100. Minhai Biotechnology Basic Information
Table 101. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 102. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Minhai Biotechnology Business Overview
Table 104. Minhai Biotechnology Recent Developments
Table 105. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Maternal Pertussis Vaccine for Newborn Protection Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type (M USD)
Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
Table 5. Maternal Pertussis Vaccine for Newborn Protection Market Size Comparison by Region (M USD)
Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Maternal Pertussis Vaccine for Newborn Protection as of 2025)
Table 11. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Maternal Pertussis Vaccine for Newborn Protection Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (K MT)
Table 27. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type (M USD)
Table 28. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) by Type (2020-2025)
Table 29. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2025)
Table 30. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) by Type (2020-2025)
Table 31. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type (2020-2025)
Table 32. Global Maternal Pertussis Vaccine for Newborn Protection Price (USD/KG) by Type (2020-2025)
Table 33. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) by Application
Table 34. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
Table 35. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2025) & (K MT)
Table 36. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2025)
Table 37. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application (2020-2025) & (M USD)
Table 38. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application (2020-2025)
Table 39. Global Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate by Application (2020-2025)
Table 40. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (K MT)
Table 41. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2025)
Table 42. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025) & (M USD)
Table 43. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025)
Table 44. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K MT)
Table 45. North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K MT)
Table 47. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025) & (M USD)
Table 50. South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K MT)
Table 51. South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025) & (M USD)
Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Production (K MT) by Region(2020-2025)
Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2025)
Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Maternal Pertussis Vaccine for Newborn Protection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Pasteur Basic Information
Table 63. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 64. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Pasteur Business Overview
Table 66. Sanofi Pasteur SWOT Analysis
Table 67. Sanofi Pasteur Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 70. GSK Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Mitsubishi Tanabe Pharma Basic Information
Table 75. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 76. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Mitsubishi Tanabe Pharma Business Overview
Table 78. Mitsubishi Tanabe Pharma SWOT Analysis
Table 79. Mitsubishi Tanabe Pharma Recent Developments
Table 80. KM Biologics Basic Information
Table 81. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 82. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. KM Biologics Business Overview
Table 84. KM Biologics Recent Developments
Table 85. Wuhan Institute of Biological Products Basic Information
Table 86. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 87. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Wuhan Institute of Biological Products Business Overview
Table 89. Wuhan Institute of Biological Products Recent Developments
Table 90. Walvax Biotechnology Basic Information
Table 91. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 92. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Walvax Biotechnology Business Overview
Table 94. Walvax Biotechnology Recent Developments
Table 95. Chengdu Institute of Biological Products Basic Information
Table 96. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 97. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Chengdu Institute of Biological Products Business Overview
Table 99. Chengdu Institute of Biological Products Recent Developments
Table 100. Minhai Biotechnology Basic Information
Table 101. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Overview
Table 102. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Minhai Biotechnology Business Overview
Table 104. Minhai Biotechnology Recent Developments
Table 105. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Maternal Pertussis Vaccine for Newborn Protection Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Maternal Pertussis Vaccine for Newborn Protection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD), 2025-2035
Figure 5. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) (2020-2035)
Figure 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Product Life Cycle
Figure 13. Maternal Pertussis Vaccine for Newborn Protection Sales Share by Manufacturers in 2025
Figure 14. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers in 2025
Figure 15. Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Maternal Pertussis Vaccine for Newborn Protection Revenue in 2025
Figure 18. Industry Chain Map of Maternal Pertussis Vaccine for Newborn Protection
Figure 19. Global Maternal Pertussis Vaccine for Newborn Protection Market PEST Analysis
Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type
Figure 27. Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2020-2025)
Figure 28. Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type in 2025
Figure 29. Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2020-2025)
Figure 30. Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application
Figure 33. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2025)
Figure 34. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application in 2025
Figure 35. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application (2020-2025)
Figure 36. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application in 2025
Figure 37. Global Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate by Application (2020-2025)
Figure 38. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2025)
Figure 39. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025)
Figure 40. North America Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2024
Figure 43. North America Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country in 2024
Figure 45. U.S. Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Maternal Pertussis Vaccine for Newborn Protection Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Maternal Pertussis Vaccine for Newborn Protection Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2024
Figure 53. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country in 2024
Figure 55. Germany Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region in 2024
Figure 67. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region in 2024
Figure 68. China Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (K MT)
Figure 79. South America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2024
Figure 80. South America Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (M USD)
Figure 81. South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country in 2024
Figure 82. Brazil Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Region in 2024
Figure 92. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Maternal Pertussis Vaccine for Newborn Protection Production Market Share by Region (2020-2025)
Figure 103. North America Maternal Pertussis Vaccine for Newborn Protection Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Maternal Pertussis Vaccine for Newborn Protection Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Maternal Pertussis Vaccine for Newborn Protection Production (K MT) Growth Rate (2020-2025)
Figure 106. China Maternal Pertussis Vaccine for Newborn Protection Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Type (2026-2035)
Figure 111. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Application (2026-2035)
Figure 112. Global Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Maternal Pertussis Vaccine for Newborn Protection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD), 2025-2035
Figure 5. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) (2020-2035)
Figure 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Product Life Cycle
Figure 13. Maternal Pertussis Vaccine for Newborn Protection Sales Share by Manufacturers in 2025
Figure 14. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers in 2025
Figure 15. Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Maternal Pertussis Vaccine for Newborn Protection Revenue in 2025
Figure 18. Industry Chain Map of Maternal Pertussis Vaccine for Newborn Protection
Figure 19. Global Maternal Pertussis Vaccine for Newborn Protection Market PEST Analysis
Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type
Figure 27. Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2020-2025)
Figure 28. Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type in 2025
Figure 29. Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2020-2025)
Figure 30. Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application
Figure 33. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2025)
Figure 34. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application in 2025
Figure 35. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application (2020-2025)
Figure 36. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application in 2025
Figure 37. Global Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate by Application (2020-2025)
Figure 38. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2025)
Figure 39. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (2020-2025)
Figure 40. North America Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2024
Figure 43. North America Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country in 2024
Figure 45. U.S. Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Maternal Pertussis Vaccine for Newborn Protection Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Maternal Pertussis Vaccine for Newborn Protection Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Maternal Pertussis Vaccine for Newborn Protection Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Maternal Pertussis Vaccine for Newborn Protection Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2024
Figure 53. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country in 2024
Figure 55. Germany Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region in 2024
Figure 67. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region in 2024
Figure 68. China Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (K MT)
Figure 79. South America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2024
Figure 80. South America Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (M USD)
Figure 81. South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country in 2024
Figure 82. Brazil Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Region in 2024
Figure 92. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Maternal Pertussis Vaccine for Newborn Protection Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Maternal Pertussis Vaccine for Newborn Protection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Maternal Pertussis Vaccine for Newborn Protection Production Market Share by Region (2020-2025)
Figure 103. North America Maternal Pertussis Vaccine for Newborn Protection Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Maternal Pertussis Vaccine for Newborn Protection Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Maternal Pertussis Vaccine for Newborn Protection Production (K MT) Growth Rate (2020-2025)
Figure 106. China Maternal Pertussis Vaccine for Newborn Protection Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Type (2026-2035)
Figure 111. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Application (2026-2035)
Figure 112. Global Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Application (2026-2035)
